<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113883.3.117.1.7.1.226" displayName="Thrombolytic (t-PA) Therapy" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="1804799" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="alteplase 100 MG Injection"/>            <ns0:Concept code="1804804" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="alteplase 50 MG Injection"/>        </ns0:ConceptList>        <ns0:Source>The Joint Commission</ns0:Source>        <ns0:Purpose>(Clinical Focus: This value set contains concepts that represent medications that are prescribed for thrombolytic (t-PA) therapy for treatment of ischemic stroke.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are administered appropriate thrombolytic (t-PA) therapy for stroke.),(Inclusion Criteria: Includes only relevant concepts associated with RxNorm thrombolytic medications appropriate for stroke treatment consistent with administration by intravenous (IV) route.),(Exclusion Criteria: No exclusions.)</ns0:Purpose>        <ns0:Type>Extensional</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2017-07-27</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>